Glenmark gets tentative nod from USFDA for epilepsy drug
Glenmark Pharmaceuticals shares were trading at Rs 787.20 in the morning deals on the BSE, down 2.95%18-03-2016
18-03-2016
Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Oral Solution, 10 mg/mL
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated March 18, 2016 titled "Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Oral Solution, 10 mg/mL".18-03-2016
Govt bans Crocin Cold and Flu, D-Cold Total
Top five companies which are going to take the hit are - Abbott, Pfizer, Macleods, Glenmark and Mankind17-03-2016
Temporary relief to Abbott, Glenmark in drug case
The government banned 344 drug combinations over the weekend, including Abbott's codeine-based cough syrup, after a government panel of experts found they had "no therapeutic justification."15-03-2016
Glenmark gets final FDA nod for migraine headache relief drug
The company's current portfolio consists of 61 ANDAs pending approvals from the US FDA14-03-2016
Glenmark Pharmaceuticals receives ANDA approval for Frovatriptan Succinate Tablets, 2.5 mg
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated March 14, 2016 titled "Glenmark Pharmaceuticals receives ANDA approval for Frovatriptan Succinate Tablets, 2.5 mg".14-03-2016
Glenmark Gets USFDA Nod for Contraceptive Tablets
According to IMS Health sales data for the 12 months to December 2015, the Ortho Tri-cyclen Lo tablets achieved annual sales of around $503.9 million, Glenmark said.24-02-2016
Glenmark Pharmaceuticals receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated February 24, 2016, titled "Glenmark Pharmaceuticals receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg".24-02-2016
Glenmark gets tentative nod from USFDA for azelaic acid gel
The patent for Finacea topical gel, 15%, is scheduled to expire on November 18, 201817-02-2016
Glenmark Pharmaceuticals receives tentative ANDA approval for Azelaic Acid Gel, 15%
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated February 17, 2016, titled "Glenmark Pharmaceuticals receives tentative ANDA approval for Azelaic Acid Gel, 15%".17-02-2016